caseins has been researched along with Cancer of Prostate in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 1 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Bang, SI; Kim, JY; Lee, SD | 1 |
| Elgindy, NA; Elzoghby, AO; Helmy, MW; Samy, WM | 1 |
| Elgindy, NA; Elzoghby, AO; Helmy, MW; Saad, NI; Samy, WM | 1 |
| Ling, MT; Wang, X; Wong, YC; Xu, K | 1 |
| Clark, DE; Jones, FE; Marrero, L; Vidal, GA | 1 |
| Sinha, AA; Wilson, MJ | 1 |
| Bakogeorgou, E; Castanas, E; Damianaki, A; Hatzoglou, A; Kampa, M; Martin, PM | 1 |
| Hedner, U; Nilsson, IM | 1 |
8 other study(ies) available for caseins and Cancer of Prostate
| Article | Year |
|---|---|
α-Casein Changes Gene Expression Profiles and Promotes Tumorigenesis of Prostate Cancer Cells.
Topics: Autophagy; Biomarkers, Tumor; Caseins; Cell Line, Tumor; Cell Proliferation; Cell Survival; Chelating Agents; E2F1 Transcription Factor; Gene Expression Regulation, Neoplastic; Humans; Male; Proliferating Cell Nuclear Antigen; Prostate; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Signal Transduction | 2020 |
Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model.
Topics: Androgens; Animals; Antineoplastic Agents, Hormonal; Caseins; Delayed-Action Preparations; Drug Carriers; Drug Compounding; Flutamide; Male; Micelles; Nanoparticles; Particle Size; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Solubility; Surface Properties | 2013 |
Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Caseins; Caspase 3; Cross-Linking Reagents; Delayed-Action Preparations; Drug Carriers; Drug Delivery Systems; Flutamide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Male; Nanoparticles; Particle Size; Polyphosphates; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley | 2013 |
Evidence of a novel biomarker, alphas1-Casein, a milk protein, in benign prostate hyperplasia.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Autopsy; Biomarkers, Tumor; Caseins; Diagnosis, Differential; Gene Expression Regulation, Neoplastic; Humans; Immunohistochemistry; Male; Middle Aged; Milk Proteins; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Prostatic Secretory Proteins; Up-Regulation | 2006 |
A constitutively active ERBB4/HER4 allele with enhanced transcriptional coactivation and cell-killing activities.
Topics: Alleles; Apoptosis; Breast Neoplasms; Caseins; Cell Nucleus; Cells, Cultured; ErbB Receptors; Female; Gene Expression Regulation, Neoplastic; Humans; Kidney; Male; Ovarian Neoplasms; Phosphorylation; Promoter Regions, Genetic; Prostatic Neoplasms; Protein Transport; Receptor, ErbB-4; STAT5 Transcription Factor; Transcription, Genetic; Transcriptional Activation; Tumor Suppressor Proteins; Tyrosine | 2007 |
Human prostate tumor angiogenesis in nude mice: metalloprotease and plasminogen activator activities during tumor growth and neovascularization of subcutaneously injected matrigel impregnated with human prostate tumor cells.
Topics: Animals; Biocompatible Materials; Caseins; Collagen; Drug Combinations; Endopeptidases; Gelatinases; Humans; Immunohistochemistry; Injections, Subcutaneous; Laminin; Male; Matrix Metalloproteinase 2; Metalloendopeptidases; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Plasminogen Activators; Prostate-Specific Antigen; Prostatic Neoplasms; Proteoglycans; Tumor Cells, Cultured; Urokinase-Type Plasminogen Activator; von Willebrand Factor | 1997 |
Opioid alkaloids and casomorphin peptides decrease the proliferation of prostatic cancer cell lines (LNCaP, PC3 and DU145) through a partial interaction with opioid receptors.
Topics: Binding Sites; Caseins; Cell Division; Cell Survival; Enkephalins; Ethylketocyclazocine; Humans; Ligands; Male; Morphinans; Narcotic Antagonists; Narcotics; Prostatic Neoplasms; Receptors, Opioid; Tumor Cells, Cultured | 1997 |
Pattern of the activator inhibitor in carcinoma and renal diseases.
Topics: Acute Kidney Injury; Antifibrinolytic Agents; Blood Urea Nitrogen; Breast Neoplasms; Caseins; Chromatography, Gel; Creatinine; Enzyme Activation; Fibrinolysis; Hodgkin Disease; Humans; Intestinal Neoplasms; Kidney Failure, Chronic; Macroglobulins; Male; Neoplasms; Pancreatic Neoplasms; Plasminogen; Prostatic Neoplasms; Uremia | 1973 |